| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.068 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |